Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for depressive symptoms in youth at high risk for bipolar disorder
NCT02865629Unknown
- Sponsor
- University of Cincinnati
- Start
- Aug 2016
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of acetylcysteine in major depressive disorder (MDD), sponsored by University of Cincinnati. Primary endpoint: Hamilton Depression Rating Scale at 8 weeks. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02865629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865629.